Transarterial therapies for hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

Transarterial therapies for hepatocellular carcinoma.

Transarterial therapies for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34628257

about

Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments TACE performed in patients with a single nodule of hepatocellular carcinoma.Intra-arterial infusion and chemo-embolization for melanoma liver metastases.Safety and efficacy of transcatheter arterial chemoemboliazation in the real-life management of unresectable hepatocellular carcinoma Cytokines for the treatment of gastrointestinal cancers: clinical experience and new perspectives.Treatment of Liver Cancer.Selective internal radiotherapy (SIRT) of hepatic tumors: how to deal with the cystic artery.Microniosomes for concurrent doxorubicin and iron oxide nanoparticles loading; preparation, characterization and cytotoxicity studies.

P2860

Q26852174-41E66CD2-29F7-4A1A-9E93-EFA8CF57F472 Q34136129-C9508525-4143-4D49-B269-D1C3C1A4C07A Q34402644-B2480F94-CA7B-487A-AFDB-A0650612DFA4 Q37283698-AA14D4F2-1F17-4B53-B605-D0182BDF2967 Q38099680-C73EB41D-B1A7-4A95-86A7-631133A5F673 Q38549768-CB0F24E3-0A47-4A8C-9BE4-BE77520BE5BD Q40063283-641A340C-9287-4190-80E0-4797ED8769A0 Q53380228-DD15E604-FD33-4391-BF43-B2A0E7453196

P2860

Transarterial therapies for hepatocellular carcinoma.

http://www.wikidata.org/entity/Q34628257

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Transarterial therapies for hepatocellular carcinoma.

@ast

Transarterial therapies for hepatocellular carcinoma.

@en

Transarterial therapies for hepatocellular carcinoma.

@nl

type

label

Transarterial therapies for hepatocellular carcinoma.

@ast

Transarterial therapies for hepatocellular carcinoma.

@en

Transarterial therapies for hepatocellular carcinoma.

@nl

prefLabel

Transarterial therapies for hepatocellular carcinoma.

@ast

Transarterial therapies for hepatocellular carcinoma.

@en

Transarterial therapies for hepatocellular carcinoma.

@nl

P1433

Q34628257-CA77B063-837B-4184-B4F2-1240EF6FF41D

P1476

Q34628257-67E9A6FE-236A-453F-830A-892BC40ED9F8

P2093

Q34628257-768CE1C4-68A8-47F7-ACF5-BD1ADDD26102

P2860

Q34628257-003705C1-A35B-43C9-8DC8-21E542CB3D09

Q34628257-013EA31D-2978-4C8A-9C46-60E5D25E6BAA

Q34628257-017252B0-0A67-4E07-9A8B-A46C8F333561

Q34628257-0542A61E-9DA7-430B-B25E-ADA5D2D5E054

Q34628257-0B3BD990-7411-4EB6-80DF-A34BC0E088F5

Q34628257-0CB72BA7-CB23-4780-825D-3723511EB97C

Q34628257-155C655E-0E65-49E4-879A-DA0B25831048

Q34628257-15ACA77F-DB3E-4B89-AAA1-332DFB567947

Q34628257-177D2271-8155-4598-A585-B6723790F7B1

Q34628257-1E5AB324-6427-487A-BA2F-AC2AA578BEA8

P304

Q34628257-74EBE2AD-90F4-4A8D-81F6-E990EB1FA9AA

P31

Q34628257-445F303D-9EFD-4749-A8AF-201414778211

P356

Q34628257-EAB0CD21-859B-426A-9B23-3AA98C0BA4EB

P407

Q34628257-A9AFB9AB-14C9-43A4-BBFD-BFF9B080E8F3

P433

Q34628257-D634AB14-4D09-4683-97C2-66BDFF5FC3FE

P478

Q34628257-26E13ABB-C9EB-402B-A35A-B26509D0DBEB

P50

Q34628257-12C8D471-B67F-458F-AB52-D38E0BEB473B

Q34628257-C024CA71-2242-4A06-B308-46AF7A5E4C91

Q34628257-D3DBD6C2-642B-412A-A7CC-C370E0D3E259

P577

Q34628257-122B697B-1E42-4883-8620-F70A71FC4F50

P698

Q34628257-DABACEC2-8EA7-40A5-A72C-BF9748B7157E

P356

14656566.2011.545346

P1433

Expert Opinion on Pharmacotherapy

P1476

Transarterial therapies for hepatocellular carcinoma

@en

P2093

Delia D'Avola

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib in advanced hepatocellular carcinoma

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients.

Technology insight: Image-guided therapies for hepatocellular carcinoma--intra-arterial and ablative techniques.

Transarterial chemoembolization as initial treatment for unresectable hepatocellular carcinoma in southern China

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.

Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma.

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.

P304

1057-1073

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2011.545346

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Mercedes Iñarrairaegui

P577

2011-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21470073

http://www.w3.org/2001/XMLSchema#string